Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 8779

1.

Denervated Myocardium Is Preferentially Associated With Sudden Cardiac Arrest in Ischemic Cardiomyopathy: A Pilot Competing Risks Analysis of Cause-Specific Mortality.

Fallavollita JA, Dare JD, Carter RL, Baldwa S, Canty JM Jr.

Circ Cardiovasc Imaging. 2017 Aug;10(8). pii: e006446. doi: 10.1161/CIRCIMAGING.117.006446.

PMID:
28794139
2.

Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator.

van Barreveld M, Dijkgraaf MGW, Hulleman M, Boersma LVA, Delnoy PPHM, Meine M, Tuinenburg AE, Theuns DAMJ, van der Voort PH, Kimman GP, Buskens E, Tijssen JPG, Bruinsma N, Verstraelen TE, Zwinderman AH, van Dessel PHFM, Wilde AAM; DO-IT investigators.

Neth Heart J. 2017 Aug 7. doi: 10.1007/s12471-017-1016-x. [Epub ahead of print]

PMID:
28785868
3.

Chagas Heart Failure in Patients from Latin America.

Bestetti RB.

Card Fail Rev. 2016 Nov;2(2):90-94. doi: 10.15420/cfr.2016:14:2.

4.

Electrophysiology Catheter Facilitated Coronary Sinus Cannulation and Implantation of Cardiac Resynchronization Therapy Systems.

Manolis AS, Koulouris S, Tsiachris D.

Hellenic J Cardiol. 2017 Aug 1. pii: S1109-9666(17)30121-5. doi: 10.1016/j.hjc.2017.07.008. [Epub ahead of print]

5.

Position of Subcutaneous Implantable Cardioverter-Defibrillators and Possible Interference on Myocardial Perfusion Imaging.

Kahaly OR, Shafiei F, Hardebeck C, Houmsse M.

Tex Heart Inst J. 2017 Jun 1;44(3):223-225. doi: 10.14503/THIJ-16-5921. eCollection 2017 Jun.

6.

Retained cardiac implantable electronic device fragments are not associated with magnetic resonance imaging safety issues, morbidity, or mortality after orthotopic heart transplant.

Austin CO, Landolfo K, Parikh PP, Patel PC, Venkatachalam KL, Kusumoto FM.

Am Heart J. 2017 Aug;190:46-53. doi: 10.1016/j.ahj.2017.04.011. Epub 2017 May 4.

PMID:
28760213
7.

Management of Implantable Cardioverter Defibrillator Recipients: Care Beyond Guidelines.

Philippon F, Sterns LD, Nery PB, Parkash R, Birnie D, Rinne C, Mondesert B, Exner D, Bennett M.

Can J Cardiol. 2017 Aug;33(8):977-990. doi: 10.1016/j.cjca.2017.05.012. Epub 2017 May 26.

PMID:
28754398
8.

Totally Leadless Dual-Device Implantation for Combined Spontaneous Ventricular Tachycardia Defibrillation and Pacemaker Function: A First Report.

Ahmed FZ, Cunnington C, Motwani M, Zaidi AM.

Can J Cardiol. 2017 Aug;33(8):1066.e5-1066.e7. doi: 10.1016/j.cjca.2017.05.017. Epub 2017 May 30.

PMID:
28754393
9.

The Dx-AF study: a prospective, multicenter, randomized controlled trial comparing VDD-ICD to VVI-ICD in detecting sub-clinical atrial fibrillation in defibrillator patients.

Shurrab M, Janmohamed A, Sarrazin JF, Ayala-Paredes F, Sturmer M, Williams R, Toal S, Lane C, Thorpe KE, Healey JS, Crystal E.

J Interv Card Electrophysiol. 2017 Jul 27. doi: 10.1007/s10840-017-0276-0. [Epub ahead of print]

PMID:
28752228
10.

Long-term complications, reoperations and survival following cardioverter-defibrillator implant.

Hawkins NM, Grubisic M, Andrade JG, Huang F, Ding L, Gao M, Bashir J.

Heart. 2017 Jul 26. pii: heartjnl-2017-311638. doi: 10.1136/heartjnl-2017-311638. [Epub ahead of print]

PMID:
28747313
11.

The last frontier: transcatheter devices for percutaneous or minimally invasive treatment of chronic heart failure.

Nijenhuis VJ, Sanchis L, van der Heyden JAS, Klein P, Rensing BJWM, Latib A, Maisano F, Ten Berg JM, Agostoni P, Swaans MJ.

Neth Heart J. 2017 Jul 24. doi: 10.1007/s12471-017-1018-8. [Epub ahead of print] Review.

PMID:
28741245
12.

Effect of Piezoelectric Units on the Implantable Cardioverter and Defibrillator.

Val GG, Jara F, Sánchez B, Roig M, Ferrer R, Duran-Sindreu F.

J Oral Maxillofac Surg. 2017 Jun 29. pii: S0278-2391(17)30726-7. doi: 10.1016/j.joms.2017.06.027. [Epub ahead of print]

PMID:
28732223
13.

Inappropriate implantable cardioverter defibrillator shocks-incidence, effect, and implications for driver licensing.

Watanabe E, Okajima K, Shimane A, Ozawa T, Manaka T, Morishima I, Asai T, Takagi M, Honda T, Kasai A, Fujii E, Yamashiro K, Kohno R, Abe H, Noda T, Kurita T, Watanabe S, Ohmori H, Nitta T, Aizawa Y, Kiyono K, Okumura K.

J Interv Card Electrophysiol. 2017 Sep;49(3):271-280. doi: 10.1007/s10840-017-0272-4. Epub 2017 Jul 20.

PMID:
28730420
14.

Contemporary Outcomes in Patients With Long QT Syndrome.

Rohatgi RK, Sugrue A, Bos JM, Cannon BC, Asirvatham SJ, Moir C, Owen HJ, Bos KM, Kruisselbrink T, Ackerman MJ.

J Am Coll Cardiol. 2017 Jul 25;70(4):453-462. doi: 10.1016/j.jacc.2017.05.046.

PMID:
28728690
15.

Infectious complications in patients with cardiac implantable electronic devices - risk factors, prevention and prognosis.

Polewczyk A, Jacheć W, Polewczyk AM, Tomasik A, Janion M, Kutarski A.

Pol Arch Intern Med. 2017 Jul 19. doi: 10.20452/pamw.4065. [Epub ahead of print]

16.

Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial.

Adabag S, Patton KK, Buxton AE, Rector TS, Ensrud KE, Vakil K, Levy WC, Poole JE.

JAMA Cardiol. 2017 Jul 1;2(7):767-774. doi: 10.1001/jamacardio.2017.1413.

PMID:
28724134
17.

Structured pain management reduces patient discomfort after catheter ablation and rhythm device surgery.

Dörschner M, Bollmann A, Dinov B, Richter S, Döring M, Arya A, Müssigbrodt A, Kircher S, Dagres N, Sommer P, Hindricks G, Bode K.

Eur J Pain. 2017 Jul 18. doi: 10.1002/ejp.1084. [Epub ahead of print]

PMID:
28722339
18.

Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.

Martens P, Verbrugge FH, Nijst P, Dupont M, Nuyens D, Herendael HV, Rivero-Ayerza M, Tang WH, Mullens W.

Heart. 2017 Jul 17. pii: heartjnl-2017-311423. doi: 10.1136/heartjnl-2017-311423. [Epub ahead of print]

PMID:
28716973
19.

Galectin-3 correlates with arrhythmogenic right ventricular cardiomyopathy and predicts the risk of ventricular -arrhythmias in patients with implantable defibrillators.

Oz F, Onur I, Elitok A, Ademoglu E, Altun I, Bilge AK, Adalet K.

Acta Cardiol. 2017 Aug;72(4):453-459. doi: 10.1080/00015385.2017.1335371. Epub 2017 Jul 14.

PMID:
28705047
20.

Clinician Attitudes Regarding ICD Deactivation in DNR/DNI Patients.

Bradley A, Marks A.

J Hosp Med. 2017 Jul;12(7):498-502. doi: 10.12788/jhm.2762.

PMID:
28699936

Supplemental Content

Loading ...
Support Center